Multiple Myeloma Clinical Trials in Atlanta

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
2022-04-04
Apr 4, 2022
N
Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Blood and Marrow Transplant Group of Georgia
2022-04-04
Apr 4, 2022
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2022-03-21
Mar 21, 2022
P
Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
2022-03-29
Mar 29, 2022
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +33 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +56 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2022-03-24
Mar 24, 2022
C
Active, not recruiting
  • Multiple Myeloma
  • bb2121 carfilzomib
  • +3 more
  • Scottsdale, Arizona
  • +18 more
2022-03-23
Mar 23, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2022-03-24
Mar 24, 2022
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +28 more
2022-03-24
Mar 24, 2022
R
Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +21 more
2022-03-22
Mar 22, 2022
N
Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +16 more
2022-03-18
Mar 18, 2022
B
No longer available
  • Multiple Myeloma
  • Elotuzumab in combination with Lenalidomide and Dexamethasone
  • Concord, California
  • +26 more
2022-03-17
Mar 17, 2022
G
Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • San Francisco, California
  • +5 more
2022-03-17
Mar 17, 2022